Cargando…

Evaluation of options for harvest of a recombinant E. Coli fermentation producing a domain antibody using ultra scale‐down techniques and pilot‐scale verification

Ultra scale‐down (USD) methods operating at the millilitre scale were used to characterise full‐scale processing of E. coli fermentation broths autolysed to different extents for release of a domain antibody. The focus was on the primary clarification stages involving continuous centrifugation follo...

Descripción completa

Detalles Bibliográficos
Autores principales: Voulgaris, Ioannis, Chatel, Alex, Hoare, Mike, Finka, Gary, Uden, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991298/
https://www.ncbi.nlm.nih.gov/pubmed/26698375
http://dx.doi.org/10.1002/btpr.2220
_version_ 1782448836188307456
author Voulgaris, Ioannis
Chatel, Alex
Hoare, Mike
Finka, Gary
Uden, Mark
author_facet Voulgaris, Ioannis
Chatel, Alex
Hoare, Mike
Finka, Gary
Uden, Mark
author_sort Voulgaris, Ioannis
collection PubMed
description Ultra scale‐down (USD) methods operating at the millilitre scale were used to characterise full‐scale processing of E. coli fermentation broths autolysed to different extents for release of a domain antibody. The focus was on the primary clarification stages involving continuous centrifugation followed by depth filtration. The performance of this sequence was predicted by USD studies to decrease significantly with increased extents of cell lysis. The use of polyethyleneimine reagent was studied to treat the lysed cell broth by precipitation of soluble contaminants such as DNA and flocculation of cell debris material. The USD studies were used to predict the impact of this treatment on the performance and here it was found that the fermentation could be run to maximum productivity using an acceptable clarification process (e.g., a centrifugation stage operating at 0.11 L/m(2) equivalent gravity settling area per hour followed by a resultant required depth filter area of 0.07 m(2)/L supernatant). A range of USD predictions was verified at the pilot scale for centrifugation followed by depth filtration. © 2016 The Authors Biotechnology Progress published by Wiley Periodicals, Inc. on behalf of American Institute of Chemical Engineers Biotechnol. Prog., 32:382–392, 2016
format Online
Article
Text
id pubmed-4991298
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-49912982016-09-06 Evaluation of options for harvest of a recombinant E. Coli fermentation producing a domain antibody using ultra scale‐down techniques and pilot‐scale verification Voulgaris, Ioannis Chatel, Alex Hoare, Mike Finka, Gary Uden, Mark Biotechnol Prog Bioseparations and Downstream Processing Ultra scale‐down (USD) methods operating at the millilitre scale were used to characterise full‐scale processing of E. coli fermentation broths autolysed to different extents for release of a domain antibody. The focus was on the primary clarification stages involving continuous centrifugation followed by depth filtration. The performance of this sequence was predicted by USD studies to decrease significantly with increased extents of cell lysis. The use of polyethyleneimine reagent was studied to treat the lysed cell broth by precipitation of soluble contaminants such as DNA and flocculation of cell debris material. The USD studies were used to predict the impact of this treatment on the performance and here it was found that the fermentation could be run to maximum productivity using an acceptable clarification process (e.g., a centrifugation stage operating at 0.11 L/m(2) equivalent gravity settling area per hour followed by a resultant required depth filter area of 0.07 m(2)/L supernatant). A range of USD predictions was verified at the pilot scale for centrifugation followed by depth filtration. © 2016 The Authors Biotechnology Progress published by Wiley Periodicals, Inc. on behalf of American Institute of Chemical Engineers Biotechnol. Prog., 32:382–392, 2016 John Wiley and Sons Inc. 2016-01-12 2016 /pmc/articles/PMC4991298/ /pubmed/26698375 http://dx.doi.org/10.1002/btpr.2220 Text en © 2016 The Authors Biotechnology Progress published by Wiley Periodicals, Inc. on behalf of American Institute of Chemical Engineers This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Bioseparations and Downstream Processing
Voulgaris, Ioannis
Chatel, Alex
Hoare, Mike
Finka, Gary
Uden, Mark
Evaluation of options for harvest of a recombinant E. Coli fermentation producing a domain antibody using ultra scale‐down techniques and pilot‐scale verification
title Evaluation of options for harvest of a recombinant E. Coli fermentation producing a domain antibody using ultra scale‐down techniques and pilot‐scale verification
title_full Evaluation of options for harvest of a recombinant E. Coli fermentation producing a domain antibody using ultra scale‐down techniques and pilot‐scale verification
title_fullStr Evaluation of options for harvest of a recombinant E. Coli fermentation producing a domain antibody using ultra scale‐down techniques and pilot‐scale verification
title_full_unstemmed Evaluation of options for harvest of a recombinant E. Coli fermentation producing a domain antibody using ultra scale‐down techniques and pilot‐scale verification
title_short Evaluation of options for harvest of a recombinant E. Coli fermentation producing a domain antibody using ultra scale‐down techniques and pilot‐scale verification
title_sort evaluation of options for harvest of a recombinant e. coli fermentation producing a domain antibody using ultra scale‐down techniques and pilot‐scale verification
topic Bioseparations and Downstream Processing
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991298/
https://www.ncbi.nlm.nih.gov/pubmed/26698375
http://dx.doi.org/10.1002/btpr.2220
work_keys_str_mv AT voulgarisioannis evaluationofoptionsforharvestofarecombinantecolifermentationproducingadomainantibodyusingultrascaledowntechniquesandpilotscaleverification
AT chatelalex evaluationofoptionsforharvestofarecombinantecolifermentationproducingadomainantibodyusingultrascaledowntechniquesandpilotscaleverification
AT hoaremike evaluationofoptionsforharvestofarecombinantecolifermentationproducingadomainantibodyusingultrascaledowntechniquesandpilotscaleverification
AT finkagary evaluationofoptionsforharvestofarecombinantecolifermentationproducingadomainantibodyusingultrascaledowntechniquesandpilotscaleverification
AT udenmark evaluationofoptionsforharvestofarecombinantecolifermentationproducingadomainantibodyusingultrascaledowntechniquesandpilotscaleverification